ArticleThe oncologist2022

Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US.

Pankit Vachhani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.